Reckitt Benckiser third-quarter sales growth misses estimates
LONDON, Oct (HKSE: 3366-OL.HK - news) 19 (Reuters) - Consumer goods maker Reckitt Benckiser Group reported a bigger than expected slowdown in third-quarter sales growth on Wednesday, hurt by the continued loss of business in South Korea due to a scandal over humidifier sanitisers.
The maker of Durex condoms and Mucinex cold medicine said like-for-like sales rose 2 percent in the quarter.
That compares with analysts' average estimate of 2.8 percent, according to a company-compiled consensus, and growth of 4 percent in the second quarter.
On a reported basis, the British company said sales rose 17 percent to 2.6 billion pounds ($3.19 billion), as the weak sterling lifted the value of overseas revenue.
Reckitt said it expects full-year sales growth of 4 percent. ($1 = 0.8149 pounds) (Reporting by Martinne Geller, editing by Louise Heavens)